Tuberculosis in HIV-infected patients: prevalence, clinical manifestations, treatment efficiency

DOI: https://doi.org/10.29296/25877305-2018-11-02
Download full text PDF
Issue: 
11
Year: 
2018

Professor R. Abdullaev(1), MD; O. Komissarova(1, 2), MD; L. Gerasimov(1, 3) 1-Central Research Institute of Tuberculosis, Moscow 2-N.I. Pirogov Russian National Research Medical University, Moscow 3-A.E. Rabukhin Tuberculosis Hospital, Solnechnogorsk, Moscow Region

The paper gives data on the prevalence of tuberculosis concurrent with HIV infection, on the clinical, radiological, and laboratory manifestations of tuberculosis, and on the efficiency of its therapy.
Keywords: 
tuberculosis
HIV infection
Mycobacterium tuberculosis
immunosuppression
clinical manifestations
treatment

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Alekseeva L.P. Osobennosti vyjavlenija, klinicheskogo techenija i lechenija bol'nyh tuberkulezom i VICh-infektsiej. Avtoref. dis. … kand. med. nauk. M., 2008; 43 s.
  2. Beljakova N.V. Sovershenstvovanie profilaktiki tuberkuleza u bol'nyh VICh-infektsiej v penitentsiarnyh uchrezhdenijah. Avtoref. dis. … kand. med. nauk. M., 2011; 26 s.
  3. Borovitskij V.S. Rentgenologicheskaja kartina tuberkuleza legkih, sochetannogo s VICh-infektsiej u bol'nyh v lechebnom uchrezhdenii FSIN // Ftiziatrija i pul'monologija. – 2018; 1: 66–7.
  4. Zimina V.N. Sovershenstvovanie diagnostiki i effektivnosti lechenija tuberkuleza u bol'nyh VICh-infektsiej pri razlichnoj stepeni immunosupressii. Avtoref. dis. … d-ra med. nauk. M., 2012; 45 s.
  5. Ivanov A.K., Shevyreva E.V., Skrynnik N.A. i dr. Lechenie bol'nyh tuberkulezom i VICh-infektsiej v dnevnom statsionare protivotuberkuleznogo dispansera. Mat-ly X Ezhegodnogo Vserossijskogo kongressa po infektsionnym boleznjam s mezhdunarodnym uchastiem. M., 2018; s. 82.
  6. Kononchuk O.N. Optimizatsija vyjavlenija tuberkuleza u bol'nyh VICh-infektsiej i prognozirovanie rasprostranennosti sochetannoj patologii na primere Kemerovskoj oblasti. Avtoref. dis. … kand. med. nauk. Novosibirsk, 2010; 23 s.
  7. Kuz'min O.A. Tuberkulez organov dyhanija v sochetanii s VICh-infektsiej. Dis. … kand. med. nauk. SPb, 2005; 126 s.
  8. Mihajlovskij A.M. Osobennosti kliniko-morfologicheskih projavlenij tuberkuleza, sochetannogo s VICh-infektsiej v Orenburgskoj oblasti. Avtoref. dis. … kand. med. nauk. M., 2011; 30 s.
  9. Nechaeva O.B. Epidemicheskaja situatsija po tuberkulezu sredi lits s VICh-infektsiej v Rossijskoj Federatsii // Tuberkulez i bolezni legkih. – 2017; 3: 13–9.
  10. Sterlikov S.A., Nechaeva O.B., Kucherjavaja D.A. i dr. Otraslevye i ekonomicheskie pokazateli protivotuberkuleznoj raboty v 2015–2016 gg. Statisticheskie materialy / M.: RIO TsNIIOIZ, 2017; 52 s.
  11. Panteleev A.M., Nikulina O.V., Dracheva M.S. i dr. Kriterii svoevremennoj diagnostiki tuberkuleza u patsientov s VICh-infektsiej // Med. sovet. – 2016; 10: 120–4.
  12. Salina T.Ju., Morozova T.I. Klinicheskie projavlenija i effektivnost' lechenija bol'nyh koinfektsiej tuberkulez/VICh-infektsija i gepatitom // Tuberkulez i bolezni legkih. – 2017; 95 (9): 25–9. DOI: 10.21292/2075-1230-2017-95-9-25-29.
  13. Galkin V.G., Elenkina Zh.V., Epifantseva N.A. i dr. TB/VICh v Rossijskoj Federatsii. Epidemiologija, osobennosti klinicheskih projavlenij i rezul'taty lechenija. Pod red. S.A. Sterlikova / M.: RIO TsNIIOIZ, 2017; 52 s.
  14. Fomenkova N.V. Klinicheskaja i laboratornaja harakteristika VICh-infektsii v sochetanii s razlichnymi formami tuberkuleza. Dis. … kand. med. nauk. SPb, 2004; 140 s.
  15. Frolova O.P., Kravchenko A.B., Martynov A.A. i dr. Organizatsija protivotuberkuleznoj pomoschi bol'nym VICh-infektsiej. Posobie dlja vrachej / M., Tver': OOO «Izdatel'stvo «Triada», 2007; 120 s.
  16. Schelkanova A.I. Osobennosti klinicheskogo techenija i effektivnost' himioterapii tuberkuleza u VICh-infitsirovannyh lits. Avtoref. dis. … kand. med. nauk. M., 2003; 24 s.
  17. Beyrer C., Wirtz A., O'Hara G. et al. The expanding epidemic of HIV-1 in the Russian Federation // PLoS Med. – 2017; 14 (11): e1002462. https://doi.org/10.1371/journal.pmed.1002462.
  18. Ellis P., Martin W., Dodd P. CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis // Peer J. – 2017; 5: e4165. DOI: 10.7717/peerj.4165.
  19. Isaakidis P., Casas E., Das M. et al. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. // Int. J. Tuberc. Lung Dis. – 2015; 19 (8): 969–78. http://dx.doi.org/10.5588/ijtld.15.0123.
  20. Kistana J., Lahera F., Otwombea K. et al. Pulmonary TB: varying radiological presentations in individuals with HIV in Soweto, South Africa // Trans. R. Soc. Trop. Med. Hyg. – 2017; 111: 132–6. DOI: 10.1093/trstmh/trx028.
  21. Lawn S., Myer L., Bekker L. et al. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa // AIDS. – 2007; 21: 335–41.
  22. Mahtab S., Coetzee D. Influence of HIV and other risk factors on tuberculosis // S. Afr. Med. J. – 2017; 107 (5): 428–34. DOI: 10.7196/SAMJ.2017.v107i5.11271.
  23. Murray J., Sonnenberg P., Shearer S. et al. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients // Am. J. Respir. Crit. Care. Med. – 1999; 159 (3): 733–40.
  24. Nglazi M., Bekker L.-G., Wood R. et al. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending collocated TB and ART services in South Africa: a retrospective cohort study // BMC Infect. Dis. – 2015; 15: 536. DOI: 10.1186/s12879-015-1275-3.
  25. Satti H., McLaughlin M., Hedt-Gauthier B. et al. Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho // PLoS One. – 2012; 7 (10): 46943.
  26. Shivacoti R., Sharma D., Mamoon G. et al. Association of HIV infection with extrapulmonary tuberculosis: a systemic review //Infection. – 2017; 1: 11–21. doi: 10.1007/s15010-016-0960-5
  27. Sinshaw Y., Alemu Sh., Fekadu A., Gizachew M. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study. // BMC Infectious Diseases. – 2017; 17: e132. DOI 10.1186/s12879-017-2238-7
  28. World Health Organization, Global tuberculosis report 2017. http://www.who.int/tb/publications/global_report/en/ (Accessed 2 August 2017).